Simvastatin	B:C0074554
enhances	O
the	O
hippocampal	O
klotho	O
in	O
a	O
rat	O
model	O
of	O
streptozotocin	O
-	O
induced	O
cognitive	O
decline	I:C0234985
.	O

Simvastatin	O
enhances	O
the	O
hippocampal	B:C0019564
klotho	O
in	O
a	O
rat	O
model	O
of	O
streptozotocin	O
-	O
induced	O
cognitive	O
decline	I:C0234985
.	O

Simvastatin	O
enhances	O
the	O
hippocampal	O
klotho	B:C0667394
in	O
a	O
rat	O
model	O
of	O
streptozotocin	O
-	O
induced	O
cognitive	O
decline	I:C0234985
.	O

Simvastatin	O
enhances	O
the	O
hippocampal	O
klotho	O
in	O
a	O
rat	B:C0034721
model	O
of	O
streptozotocin	O
-	O
induced	O
cognitive	O
decline	I:C0234985
.	O

Simvastatin	O
enhances	O
the	O
hippocampal	O
klotho	O
in	O
a	O
rat	O
model	B:C0012644
of	O
streptozotocin	O
-	O
induced	O
cognitive	O
decline	I:C0234985
.	O

Simvastatin	O
enhances	O
the	O
hippocampal	O
klotho	O
in	O
a	O
rat	O
model	O
of	O
streptozotocin	B:C0038432
-	O
induced	O
cognitive	O
decline	I:C0234985
.	O

Simvastatin	O
enhances	O
the	O
hippocampal	O
klotho	O
in	O
a	O
rat	O
model	O
of	O
streptozotocin	O
-	O
induced	O
cognitive	B:C0234985
decline	I:C0234985
.	O

Brain	B:C0006104
oxidative	O
status	O
is	O
a	O
crucial	O
factor	O
in	O
the	O
development	O
of	O
sporadic	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
.	O

Brain	O
oxidative	O
status	O
is	O
a	O
crucial	O
factor	O
in	O
the	O
development	O
of	O
sporadic	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
.	O

Brain	O
oxidative	O
status	O
is	O
a	O
crucial	O
factor	O
in	O
the	O
development	O
of	O
sporadic	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
)	O
.	O

Klotho	B:C0667394
,	O
an	O
anti-aging	O
protein	I:C0033684
,	O
diminishes	O
oxidative	O
stress	I:C0242606
by	O
the	O
induction	O
of	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
(	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
)	O
.	O

Klotho	O
,	O
an	O
anti-aging	B:C0033684
protein	I:C0033684
,	O
diminishes	O
oxidative	O
stress	I:C0242606
by	O
the	O
induction	O
of	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
(	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
)	O
.	O

Klotho	O
,	O
an	O
anti-aging	O
protein	I:C0033684
,	O
diminishes	O
oxidative	B:C0242606
stress	I:C0242606
by	O
the	O
induction	O
of	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
(	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
)	O
.	O

Klotho	O
,	O
an	O
anti-aging	O
protein	I:C0033684
,	O
diminishes	O
oxidative	O
stress	I:C0242606
by	O
the	O
induction	O
of	O
manganese	B:C0024708
superoxide	I:C0024708
dismutase	I:C0024708
(	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
)	O
.	O

Klotho	O
,	O
an	O
anti-aging	O
protein	I:C0033684
,	O
diminishes	O
oxidative	O
stress	I:C0242606
by	O
the	O
induction	O
of	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
(	O
manganese	B:C0024708
superoxide	I:C0024708
dismutase	I:C0024708
)	O
.	O

Thus	O
,	O
the	O
substances	O
that	O
increase	O
klotho	B:C0667394
expression	O
could	O
be	O
considered	O
as	O
a	O
potential	O
treatment	O
for	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
when	O
the	O
oxidative	O
imbalance	I:C0242606
is	O
present	O
.	O

Thus	O
,	O
the	O
substances	O
that	O
increase	O
klotho	O
expression	B:C1171362
could	O
be	O
considered	O
as	O
a	O
potential	O
treatment	O
for	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
when	O
the	O
oxidative	O
imbalance	I:C0242606
is	O
present	O
.	O

Thus	O
,	O
the	O
substances	O
that	O
increase	O
klotho	O
expression	O
could	O
be	O
considered	O
as	O
a	O
potential	O
treatment	B:C0087111
for	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
when	O
the	O
oxidative	O
imbalance	I:C0242606
is	O
present	O
.	O

Thus	O
,	O
the	O
substances	O
that	O
increase	O
klotho	O
expression	O
could	O
be	O
considered	O
as	O
a	O
potential	O
treatment	O
for	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
when	O
the	O
oxidative	O
imbalance	I:C0242606
is	O
present	O
.	O

Thus	O
,	O
the	O
substances	O
that	O
increase	O
klotho	O
expression	O
could	O
be	O
considered	O
as	O
a	O
potential	O
treatment	O
for	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
when	O
the	O
oxidative	B:C0242606
imbalance	I:C0242606
is	O
present	O
.	O

Statins	B:C0360714
are	O
suggested	O
to	O
up	O
-	I:C0041904
regulate	I:C0041904
klotho	O
expression	O
.	O

Statins	O
are	O
suggested	O
to	O
up	B:C0041904
-	I:C0041904
regulate	I:C0041904
klotho	O
expression	O
.	O

Statins	O
are	O
suggested	O
to	O
up	O
-	I:C0041904
regulate	I:C0041904
klotho	B:C0667394
expression	O
.	O

Statins	O
are	O
suggested	O
to	O
up	O
-	I:C0041904
regulate	I:C0041904
klotho	O
expression	B:C1171362
.	O

We	O
examined	O
the	O
effect	O
of	O
simvastatin	B:C0074554
(	O
5	O
mg/	O
kg	O
,	O
daily	O
for	O
3	O
weeks	O
)	O
on	O
hippocampal	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
expression	O
in	O
the	O
cognitive	O
declined	I:C0234985
animal	O
model	I:C0012644
induced	O
by	O
intracerebroventricular	O
(	O
intracerebroventricular	O
)	O
-	O
streptozotocin	O
(	O
streptozotocin	O
)	O
administration	O
.	O

We	O
examined	O
the	O
effect	O
of	O
simvastatin	O
(	O
5	O
mg/	O
kg	O
,	O
daily	O
for	O
3	O
weeks	O
)	O
on	O
hippocampal	B:C0019564
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
expression	O
in	O
the	O
cognitive	O
declined	I:C0234985
animal	O
model	I:C0012644
induced	O
by	O
intracerebroventricular	O
(	O
intracerebroventricular	O
)	O
-	O
streptozotocin	O
(	O
streptozotocin	O
)	O
administration	O
.	O

We	O
examined	O
the	O
effect	O
of	O
simvastatin	O
(	O
5	O
mg/	O
kg	O
,	O
daily	O
for	O
3	O
weeks	O
)	O
on	O
hippocampal	O
klotho	B:C0667394
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
expression	O
in	O
the	O
cognitive	O
declined	I:C0234985
animal	O
model	I:C0012644
induced	O
by	O
intracerebroventricular	O
(	O
intracerebroventricular	O
)	O
-	O
streptozotocin	O
(	O
streptozotocin	O
)	O
administration	O
.	O

We	O
examined	O
the	O
effect	O
of	O
simvastatin	O
(	O
5	O
mg/	O
kg	O
,	O
daily	O
for	O
3	O
weeks	O
)	O
on	O
hippocampal	O
klotho	O
and	O
manganese	B:C0024708
superoxide	I:C0024708
dismutase	I:C0024708
expression	O
in	O
the	O
cognitive	O
declined	I:C0234985
animal	O
model	I:C0012644
induced	O
by	O
intracerebroventricular	O
(	O
intracerebroventricular	O
)	O
-	O
streptozotocin	O
(	O
streptozotocin	O
)	O
administration	O
.	O

We	O
examined	O
the	O
effect	O
of	O
simvastatin	O
(	O
5	O
mg/	O
kg	O
,	O
daily	O
for	O
3	O
weeks	O
)	O
on	O
hippocampal	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
expression	B:C1171362
in	O
the	O
cognitive	O
declined	I:C0234985
animal	O
model	I:C0012644
induced	O
by	O
intracerebroventricular	O
(	O
intracerebroventricular	O
)	O
-	O
streptozotocin	O
(	O
streptozotocin	O
)	O
administration	O
.	O

We	O
examined	O
the	O
effect	O
of	O
simvastatin	O
(	O
5	O
mg/	O
kg	O
,	O
daily	O
for	O
3	O
weeks	O
)	O
on	O
hippocampal	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
expression	O
in	O
the	O
cognitive	B:C0234985
declined	I:C0234985
animal	O
model	I:C0012644
induced	O
by	O
intracerebroventricular	O
(	O
intracerebroventricular	O
)	O
-	O
streptozotocin	O
(	O
streptozotocin	O
)	O
administration	O
.	O

We	O
examined	O
the	O
effect	O
of	O
simvastatin	O
(	O
5	O
mg/	O
kg	O
,	O
daily	O
for	O
3	O
weeks	O
)	O
on	O
hippocampal	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
expression	O
in	O
the	O
cognitive	O
declined	I:C0234985
animal	B:C0012644
model	I:C0012644
induced	O
by	O
intracerebroventricular	O
(	O
intracerebroventricular	O
)	O
-	O
streptozotocin	O
(	O
streptozotocin	O
)	O
administration	O
.	O

We	O
examined	O
the	O
effect	O
of	O
simvastatin	O
(	O
5	O
mg/	O
kg	O
,	O
daily	O
for	O
3	O
weeks	O
)	O
on	O
hippocampal	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
expression	O
in	O
the	O
cognitive	O
declined	I:C0234985
animal	O
model	I:C0012644
induced	O
by	O
intracerebroventricular	B:C0595818
(	O
intracerebroventricular	O
)	O
-	O
streptozotocin	O
(	O
streptozotocin	O
)	O
administration	O
.	O

We	O
examined	O
the	O
effect	O
of	O
simvastatin	O
(	O
5	O
mg/	O
kg	O
,	O
daily	O
for	O
3	O
weeks	O
)	O
on	O
hippocampal	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
expression	O
in	O
the	O
cognitive	O
declined	I:C0234985
animal	O
model	I:C0012644
induced	O
by	O
intracerebroventricular	O
(	O
intracerebroventricular	B:C0595818
)	O
-	O
streptozotocin	O
(	O
streptozotocin	O
)	O
administration	O
.	O

We	O
examined	O
the	O
effect	O
of	O
simvastatin	O
(	O
5	O
mg/	O
kg	O
,	O
daily	O
for	O
3	O
weeks	O
)	O
on	O
hippocampal	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
expression	O
in	O
the	O
cognitive	O
declined	I:C0234985
animal	O
model	I:C0012644
induced	O
by	O
intracerebroventricular	O
(	O
intracerebroventricular	O
)	O
-	O
streptozotocin	B:C0038432
(	O
streptozotocin	O
)	O
administration	O
.	O

We	O
examined	O
the	O
effect	O
of	O
simvastatin	O
(	O
5	O
mg/	O
kg	O
,	O
daily	O
for	O
3	O
weeks	O
)	O
on	O
hippocampal	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
expression	O
in	O
the	O
cognitive	O
declined	I:C0234985
animal	O
model	I:C0012644
induced	O
by	O
intracerebroventricular	O
(	O
intracerebroventricular	O
)	O
-	O
streptozotocin	O
(	O
streptozotocin	B:C0038432
)	O
administration	O
.	O

We	O
examined	O
the	O
effect	O
of	O
simvastatin	O
(	O
5	O
mg/	O
kg	O
,	O
daily	O
for	O
3	O
weeks	O
)	O
on	O
hippocampal	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
expression	O
in	O
the	O
cognitive	O
declined	I:C0234985
animal	O
model	I:C0012644
induced	O
by	O
intracerebroventricular	O
(	O
intracerebroventricular	O
)	O
-	O
streptozotocin	O
(	O
streptozotocin	O
)	O
administration	B:C1533734
.	O

Cognitive	B:C0870300
assessment	I:C0870300
was	O
performed	O
by	O
the	O
Morris	O
Water	O
Maze	O
(	O
MWM	O
)	O
test	O
.	O

The	O
results	O
indicated	O
that	O
mean	O
escape	O
latency	O
and	O
distance	O
were	O
prolonged	O
in	O
the	O
intracerebroventricular	B:C0595818
-	O
streptozotocin	O
group	O
compared	O
with	O
the	O
control	O
group	O
.	O

The	O
results	O
indicated	O
that	O
mean	O
escape	O
latency	O
and	O
distance	O
were	O
prolonged	O
in	O
the	O
intracerebroventricular	O
-	O
streptozotocin	B:C0038432
group	O
compared	O
with	O
the	O
control	O
group	O
.	O

The	O
expression	B:C1171362
of	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
were	O
also	O
down	O
regulated	I:C0013081
in	O
the	O
hippocampus	O
.	O

The	O
expression	O
of	O
klotho	B:C0667394
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
were	O
also	O
down	O
regulated	I:C0013081
in	O
the	O
hippocampus	O
.	O

The	O
expression	O
of	O
klotho	O
and	O
manganese	B:C0024708
superoxide	I:C0024708
dismutase	I:C0024708
were	O
also	O
down	O
regulated	I:C0013081
in	O
the	O
hippocampus	O
.	O

The	O
expression	O
of	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
were	O
also	O
down	B:C0013081
regulated	I:C0013081
in	O
the	O
hippocampus	O
.	O

The	O
expression	O
of	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
were	O
also	O
down	O
regulated	I:C0013081
in	O
the	O
hippocampus	B:C0019564
.	O

Furthermore	O
,	O
improved	O
spatial	O
performance	O
was	O
observed	O
in	O
simvastatin	B:C0074554
-	O
treated	O
animals	O
.	O

Furthermore	O
,	O
improved	O
spatial	O
performance	O
was	O
observed	O
in	O
simvastatin	O
-	O
treated	O
animals	B:C0003062
.	O

This	O
effect	O
could	O
be	O
related	O
to	O
increase	O
in	O
oxidative	B:C0242606
stress	I:C0242606
tolerance	O
as	O
evidenced	O
by	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
up	O
-	I:C0041904
regulation	I:C0041904
.	O

This	O
effect	O
could	O
be	O
related	O
to	O
increase	O
in	O
oxidative	O
stress	I:C0242606
tolerance	O
as	O
evidenced	O
by	O
klotho	B:C0667394
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
up	O
-	I:C0041904
regulation	I:C0041904
.	O

This	O
effect	O
could	O
be	O
related	O
to	O
increase	O
in	O
oxidative	O
stress	I:C0242606
tolerance	O
as	O
evidenced	O
by	O
klotho	O
and	O
manganese	B:C0024708
superoxide	I:C0024708
dismutase	I:C0024708
up	O
-	I:C0041904
regulation	I:C0041904
.	O

This	O
effect	O
could	O
be	O
related	O
to	O
increase	O
in	O
oxidative	O
stress	I:C0242606
tolerance	O
as	O
evidenced	O
by	O
klotho	O
and	O
manganese	O
superoxide	I:C0024708
dismutase	I:C0024708
up	B:C0041904
-	I:C0041904
regulation	I:C0041904
.	O

Our	O
current	O
study	O
indicates	O
that	O
klotho	B:C0667394
upregulation	O
may	O
be	O
a	O
neuroprotective	O
mechanism	O
of	O
simvastatin	O
against	O
cognitive	O
decline	I:C0234985
in	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
.	O

Our	O
current	O
study	O
indicates	O
that	O
klotho	O
upregulation	B:C0041904
may	O
be	O
a	O
neuroprotective	O
mechanism	O
of	O
simvastatin	O
against	O
cognitive	O
decline	I:C0234985
in	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
.	O

Our	O
current	O
study	O
indicates	O
that	O
klotho	O
upregulation	O
may	O
be	O
a	O
neuroprotective	O
mechanism	O
of	O
simvastatin	B:C0074554
against	O
cognitive	O
decline	I:C0234985
in	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
.	O

Our	O
current	O
study	O
indicates	O
that	O
klotho	O
upregulation	O
may	O
be	O
a	O
neuroprotective	O
mechanism	O
of	O
simvastatin	O
against	O
cognitive	B:C0234985
decline	I:C0234985
in	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
.	O

Our	O
current	O
study	O
indicates	O
that	O
klotho	O
upregulation	O
may	O
be	O
a	O
neuroprotective	O
mechanism	O
of	O
simvastatin	O
against	O
cognitive	O
decline	I:C0234985
in	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
.	O

